昂利康：关于获得药品补充申请批准通知书的公告

Group 1 - The core point of the article is that Anglikon has received a notification from the National Medical Products Administration regarding the approval of the supplementary application for Domperidone tablets [2] Group 2 - The announcement was made on February 25, indicating a significant regulatory milestone for the company [2] - The approval is expected to enhance the company's product portfolio and market presence in the pharmaceutical industry [2]